Abstract
The association of human papillomavirus type 57 (HPV-57) with premalignant and malignant tumors of the nasal cavity was previously reported (Wu et al., Lancet341, 522, 1993). We determined the complete nucleotide sequence of HPV-57b (GenBank 37537), which was molecularly cloned from a benign fungiform papilloma, and compared it with other HPV types and HPV-57a, which was cloned from an inverted papilloma of the maxillary sinus by de Villiers et al. (Virology171, 248. 1989). Comparative and phylogenetic analysis of amino acid sequences of the HPV-57b oncogenes E5, E6, and E7 were performed with HPV-6, 11, 16, and 18. Phylogenetic trees using the Jotun-Hein algorithm indicated a closer relationship of HPV-57b E5 and E7 with corresponding genes of HPV-18. Signature pattern analysis of these two oncogenes was also in agreement with a closer relatedness to HPV-16 and 18 oncogenes, which are associated with a high risk for malignant progression. Compared with 7861 bp of HPV-57a, HPV-57b had 7868 bp as well as differences in the restriction enzyme sites and the open reading frames, including at least five additional ones. To investigate the oncogenic potential of HPV-57b, NIH 3T3 and REF52 cells were cotransfected with two plasmids: pKP54.HPV-57b, which contains the HPV-57b genome, and pMT.neo. 1, which confers resistance to G418. After selection in culture medium containing G418, 58% of the G418r NIH 3T3 colonies and 47% of the G418r REF52 colonies exhibited morphological transformation. These results indicate that the transcriptional regulatory elements and the oncoproteins of HPV-57b are active in vitro to induce cellular transformation, as are other high-risk HPV types.
Similar content being viewed by others
References
BarbosaM.S., VassW.C., LowyD.R., and SchillerJ.T., J Virol65, 292–298, 1991.
BrintonL.A., MuñozN., BoschF.X., ShahK.V., and MeheusA. (eds).The Epidemiology of Cervical Cancer and Human Papillomavirus. International Agency for Research on Cancer, Lyon, France, 1992, pp 3–23.
DalingJ.R. and ShermanK.J., MuñozN., BoschF.X., ShahK.V., and MeheusA. (eds).The Epidemiology of Cervical Cancer and Human Papillomavirus. International Agency for Research on Cancer, Lyon, France, 1992, pp 223–241.
DürstM., GissmannL., IkenbergH., and zurHausenH., Proc Natl Acad Sci USA80, 3812–3815, 1983.
SchiffmanM.H., zurHausenH. (ed).Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 131–156.
WuT.-C., TrujilloJ.M., KashimaH.K., and MountsP., Lancet341, 522–524, 1993.
zurHausenH., zurHausenH. (ed)Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 131–156.
DanosO., GiriI., ThierryF., and YanivM., J Invest Dermatol83, 7s-11s, 1984.
deVilliersE.-M., zurHausenH. (ed).Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 1–12.
deVilliersE.-M., Hirsch-BehnamA., vonKnebel-DoebritzC., NeumanC., and zurHausenH., Virology171, 248–253, 1989.
VanRanstM., KaplanJ.B., and BurkR.D., J Gen Virol73, 2653–2660, 1992.
zurHausenH., RigbyP.W.J. and WilkieN.M. (eds).Viruses and Cancer. Cambridge University Press, Cambridge, 1986, pp 83–90.
DickensP., SrivastavaG., LokeS.L., and, LarkinS., J Pathol165 243–246, 1991.
GissmannL., DiehlV., Schulz-CoulonH.-J., and zurHausenH., J Virol44, 393–400, 1982.
MountsP., ShahK.V., and KashimaH., Proc Natl Acad Sci USA79, 5425–5429, 1982.
OrthG., JablonskaS., Jarzabek-ChorzelskaM., RsezaS., ObalekS., FavreM., and CroissantO., Cancer Res39, 1074–1082, 1979.
YousemS.A., OhoriN.P., and Sonmez-AlpanE., Cancer69, 693–697, 1992.
BrandsmaJ.L. and AbramsonA.L., Cancer Res46, 2185–2188, 1989.
LöningT., IkenbergH., BeckerJ., GissmannL., HoepfnerI., and zurHausenH., J Invest Dermatol84, 417–420, 1985.
JablonskaS., PfisterH. (ed).Papillomaviruses and Human Cancer. CRC Press, Boca Raton FL, 1990, pp 46–71.
RübbenA., KronesR., SchwetschenauB., and Grussendorf-ConenE.-I., Br J Dermatol128 264–270, 1993.
LunguO., CrumC.P., and SilversteinS., J Virol65, 4216–4225, 1991.
PirisiL., YasumotoS., FelleryM., DoningerJ.K., and DiPaoloJ.A., J Virol61, 1061–1066, 1987.
KasherM.S. and RomanA., Virology165, 225–233, 1988.
McGlennenR.C., GhaiJ., OstrowR.S., LaBreshK., SchneiderJ.F., and FarasA.J., Cancer Res52, 5872–5878, 1992.
SangerF. and CoulsonA.R., J Mol Biol94, 441–448, 1975.
WilburW.J. and LipmanD.J., Proc Natl Acad Sci USA80, 726–730, 1983.
HeinJ.J., Methods Enzymol183, 626–645, 1990.
LipmanD.J. and PearsonW.R., Science227, 1435–1441, 1985.
KorberB. and MyersG., AIDS Res Hum Retroviruses8, 1549–1560, 1992.
HalbertC.L. and GallowayD.A., J Virol62, 1071–1075, 1989.
ChinM.T., BrokerT.R., and ChowL.T.,J Virol63, 2967–2976, 1989.
WardP. and MountsP., J Gen Virol19, 1671–1682, 1988.
ChenS.-L. and MountsP., J Virol64, 3226–3243, 1990.
LoganJ., NicholasJ.C., ToppW.C., GirardM., ShenkT., and LevineA.J., Virology115, 419–422, 1981.
Hirsch-BehnamA., DeliusH., and deVilliersE.-M., Virus Res18, 81–98, 1990.
ColeS.T. and DanosO., J Mol Biol193, 599–608, 1987.
FaisstS. and MeyerS., Nucleic Acids Res20, 3–26, 1992.
SettlemanJ., FazeliA., MalickiJ., HorwitzB.H., and DiMaioD., Mol Cel Biol9, 5563–5572, 1989.
RomanczykH., VillaL.L., SchlegelR., HowleyP.M., J Virol65, 2739–2744, 1991.
ScheffnerM., RomanczukH., MüngerK., HuibregsteJ.M., MietzJ.A., HowleyP.M., zurHausenH. (ed).Human Pathogenic Papillomaviruses. Springer-Verlag, Berlin, 1994, pp 131–156.
WatanabeS., KandaT., and YoshikeK., J Virol63, 965–969, 1989.
BakerC.C., SalzmanN.P., and HowleyP.M. (eds).The Papovaviridae, Vol 2. Plenum Press, New York, 1986, pp 1–38.
DartmannK., SchwartzE., GissmannL., and zurHausenH., Virology151, 124–130, 1986.
SchwarzE., DürstM., DemankowskiC., LattermannO., ZechR., WolfspergerE., SuhaiS., and zurHausenH., EMBO J2, 2341–2348, 1983.
ChanS.-Y., DeliusH., HalpernA.L., and BernardH.U., J Virol69, 3074–3083, 1995.
BoschX.F., ManosM.M., MuñozN., ShermanM., JansenA.M., PetoJ., SchiffmanM.H., MorenoV., KurmanR., and ShahK.V., Natl Cancer Inst87, 796–802, 1995.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trujillo, J.M., Wu, TC. & Mounts, P. Characterization of human papillomavirus type 57b: Transforming activity and comparative sequence analysis as probes for biological determinants associated with high-risk oncogenic viruses. Virus Genes 12, 165–178 (1996). https://doi.org/10.1007/BF00572955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00572955